StockNews.AI
NVST
StockNews.AI
41 days

Envista Schedules Second Quarter 2025 Earnings Call

1. Envista will report Q2 2025 results on July 31, 2025. 2. Investors can access the earnings call via conference ID #63445. 3. Envista is a leading player in the global dental products market. 4. The call reflects Envista's commitment to transparency with investors. 5. Webcast and materials will be available on Envista's investor website.

Earnings
+1.67%Current Return
VS
+0.28%S&P 500
$20.3807/09 04:24 PM EDTEvent Start
$20.7207/10 10:57 PM EDTLatest Updated
5m saved
Insight
Article

FAQ

Why Neutral?

The earnings report may not be surprising; previous earnings showed stable trends.

How important is it?

The earnings report's actual outcomes and guidance will heavily influence investor sentiment.

Why Short Term?

Earnings reports typically affect stock prices in the short term, especially on announcement days.

Related Companies

DENTSPLY SIRONA Inc. (XRAY)Henry Schein Inc. (HSIC)Straumann Holding AG (STMN)
, /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2025 on Thursday, July 31, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation. You can access the conference call by dialing 1-800-836-8184 within the U.S. or +1 646-357-8785 outside the U.S. a few minutes before 2:00 PM PT and referencing Conference ID #63445. Envista's earnings press release, the webcast slides, and other related presentation materials will be posted to the "Investors" section of Envista's website before the conference call and will remain available following the call. ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com. FOR FURTHER INFORMATIONJim GustafsonVice President, Investor RelationsEnvista Holdings Corporation200 S. Kraemer Blvd., Building EBrea, CA 92821Telephone: (714) 817-7000[email protected]  SOURCE Envista Holdings Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News